Overview

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic complications based on a Platelet Function Test (PFT).
Phase:
Phase 4
Details
Lead Sponsor:
Fundación EPIC
Treatments:
Clopidogrel